Martina Mayr

Phase II Trial of a 24-Hour Infusion of Gemcitabine in Previously Untreated Patients with Advanced Pancreatic Adenocarcinoma

C. Lersch, F. Eckel, R. Schmelz, 2003, Cancer investigation.

Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study

E. Compérat, J. Orme, G. Schäfer, 2021, Journal of clinical medicine.

Pancreatic cancer and depression: myth and truth

R. Schmid, M. Mayr, R. M. Schmid, 2010, BMC Cancer.

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study

H. Adelsberger, R. Schmid, F. Obermeier, 2006, Investigational New Drugs.

Truncated IRAG variants modulate cGMP-mediated inhibition of human colonic smooth muscle cell contraction.

D. Saur, F. Hofmann, J. Schlossmann, 2011, American journal of physiology. Cell physiology.

Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.

H. Adelsberger, J. Grosskreutz, C. Lersch, 2002, Clinical colorectal cancer.

Depression in Pancreatic Cancer: Sense of Impending Doom

R. Schmid, M. Mayr, Martina Mayr, 2010, Digestion.

Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma

R. Schmid, S. von Delius, C. Lersch, 2005, BMC Cancer.